TY - JOUR
T1 - Guidelines for Cord Blood Unit Selection
AU - American Society for Transplantation and Cellular Therapy Cord Blood Special Interest Group
AU - Politikos, Ioannis
AU - Davis, Eric
AU - Nhaissi, Melissa
AU - Wagner, John E.
AU - Brunstein, Claudio G.
AU - Cohen, Sandra
AU - Shpall, Elizabeth J.
AU - Milano, Filippo
AU - Scaradavou, Andromachi
AU - Barker, Juliet N.
N1 - Publisher Copyright:
© 2020 American Society for Transplantation and Cellular Therapy
PY - 2020/12
Y1 - 2020/12
N2 - Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplantation (CBT). However, unit selection can be complex because multiple characteristics must be considered including unit cell dose, donor-recipient human leukocyte antigen (HLA) match, and unit quality. This review provides evidence-based and experience-based comprehensive guidelines for CB unit selection. Topics addressed include the use of both the TNC and the CD34+ cell dose, as well as the CD34+ cell to TNC content ratio to evaluate unit progenitor cell content and engraftment potential, the acceptable TNC and CD34+ cell dose criteria that define an adequate single-unit graft, and the indication and acceptable cell dose criteria for double-unit grafts. The acceptable criteria for 6-loci (HLA-A, -B antigen, -DRB1 allele) and 8-allele (HLA-A, -B, -C, -DRB1) donor-recipient HLA match, the evaluation of patients with donor-specific HLA antibodies, and the multiple determinants of unit quality are also reviewed in detail. Finally, a practical step-by-step guide to CB searches and the principles that guide ultimate graft selection are outlined.
AB - Optimal cord blood (CB) unit selection is critical to maximize the likelihood of successful engraftment and survival after CB transplantation (CBT). However, unit selection can be complex because multiple characteristics must be considered including unit cell dose, donor-recipient human leukocyte antigen (HLA) match, and unit quality. This review provides evidence-based and experience-based comprehensive guidelines for CB unit selection. Topics addressed include the use of both the TNC and the CD34+ cell dose, as well as the CD34+ cell to TNC content ratio to evaluate unit progenitor cell content and engraftment potential, the acceptable TNC and CD34+ cell dose criteria that define an adequate single-unit graft, and the indication and acceptable cell dose criteria for double-unit grafts. The acceptable criteria for 6-loci (HLA-A, -B antigen, -DRB1 allele) and 8-allele (HLA-A, -B, -C, -DRB1) donor-recipient HLA match, the evaluation of patients with donor-specific HLA antibodies, and the multiple determinants of unit quality are also reviewed in detail. Finally, a practical step-by-step guide to CB searches and the principles that guide ultimate graft selection are outlined.
KW - CB unit selection
KW - CD34+ cell dose
KW - HLA match
KW - TNC dose
UR - http://www.scopus.com/inward/record.url?scp=85092013767&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85092013767&partnerID=8YFLogxK
U2 - 10.1016/j.bbmt.2020.07.030
DO - 10.1016/j.bbmt.2020.07.030
M3 - Article
C2 - 32736011
AN - SCOPUS:85092013767
SN - 1083-8791
VL - 26
SP - 2190
EP - 2196
JO - Biology of Blood and Marrow Transplantation
JF - Biology of Blood and Marrow Transplantation
IS - 12
ER -